Eubel Brady & Suttman Asset Management’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.6M Sell
1,012,719
-14,781
-1% -$350K 3.04% 13
2026
Q1
$22.5M Buy
1,027,500
+189,177
+23% +$4.39M 2.66% 14
2025
Q4
$19.5M Sell
838,323
-51,315
-6% -$1.24M 2.19% 17
2025
Q3
$25.2M Buy
889,638
+3,493
+0.4% +$92.8K 2.89% 14
2025
Q2
$19.5M Buy
886,145
+212,949
+32% +$4.66M 2.46% 19
2025
Q1
$15.7M Buy
673,196
+113,957
+20% +$2.91M 2.06% 23
2024
Q4
$16.1M Buy
559,239
+3,887
+0.7% +$116K 2.12% 22
2024
Q3
$16.5M Buy
+555,352
New +$17.2M 2.15% 22

Other funds holding GNTX

Eubel Brady & Suttman Asset Management's GNTX Position: Q2 2026 in Review

Eubel Brady & Suttman Asset Management reduced its Gentex (GNTX) stake by 1.4% in Q2 2026, selling an estimated $350K and leaving 1,012,719 shares worth $25.6M. The position accounts for 3.04% of the portfolio, ranked #13.

Eubel Brady & Suttman Asset Management first reported a position in GNTX in Q3 2024 and has held it in 8 quarters since. 531 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Eubel Brady & Suttman Asset Management held 1,012,719 shares of Gentex worth $25.6M as of Q2 2026.
  • Eubel Brady & Suttman Asset Management sold 14,781 Gentex shares in Q2 2026, an estimated $350K.
  • Gentex made up 3.04% of Eubel Brady & Suttman Asset Management's portfolio in Q2 2026, its #13 holding.
  • Eubel Brady & Suttman Asset Management first reported a position in Gentex in Q3 2024 and has held it in 8 quarters since.
  • 531 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.